Prediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient Setting
Key facts
- Where
- Munich, GermanySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT05547711, who can take part
Where in Germany
- Department of Psychiatry and Psychotherapy, University Hospital LMUMunich, GermanyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Julia Eder
- Trial code
- NCT05547711
- Record updated
- 21 September 2022
- Original description
The POKAL-PSY project is a study that monitors participants for five years. The goal of the study is to identify distinguishable subtypes of depression on the basis of biomarkers and to gain insight into their prognostic significance.Read full original descriptionShow less
The POKAL-PSY project is a study that monitors participants for five years. The goal of the study is to identify distinguishable subtypes of depression on the basis of biomarkers and to gain insight into their prognostic significance.
Inclusion: (PHQ>8) if depressed; Subjects of any sex aged between 18-70; Sufficient ability to speak and understand the german language; Ability to understand and sign the informed consent form.
Exclusion: Cognitive impairment that interferes with reliable completion of questionnaires or answering questions; Presence of manic episode, bipolar disorder, Schizophrenia or schizoaffective disorder (as well as other diseases in the F2 domain in the ICD), active eating disorder, active drug or alcohol dependence syndrome; Presence of uncontrolled systemic disease (e.g. autoimmune disease), uncontrolles somatic (other than metabolic or cardiovascular)/ neurologic diseases, current or recent (last month) physical trauma; Patient with acute suicidal ideation; known deficiency of alpha-1-antitrypsin; pregnant or lactating women.